COVID-19-Associated ST Elevated Myocardial Infarction with Atrial Fibrillation: A Case Report

Document Type : Case Report


1 Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Kalimantan, Indonesia.

2 Department of Internal Medicine, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Kalimantan, Indonesia.

3 Department of Cardiology and Vascular Medicine, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Kalimantan, Indonesia.


Coronavirus disease 2019 (COVID-19) displays  various clinical manifestations, and mounting evidence suggests that COVID-19 has extrapulmonary and cardiovascular involvement. Although cardiac effects are less prevalent in COVID-19 than pulmonary manifestations, understanding potential cardiac issues with COVID-19 is critical for risk stratification and improving outcomes. We report a male patient aged 56 years who presented with sudden onset of chest pain and dyspnea. The patient has a history of both hypertension and stroke. He has never traveled abroad or had previous contact with a COVID-19-positive patient. Physical examination demonstrates tachypnoea, desaturation, increased JVP, bronchial breath sounds, and rhonchi on the right basal lung. Inflammatory markers, liver function, and CKMB levels were all elevated in the laboratories. . Infiltrates and cardiomegaly were observed on a chest X-ray. Sinus tachycardia, irregular rhythm, and ST elevation on lead V1-V5 were detected on the electrocardiogram. Our patient was diagnosed with COVID-19 critical degree with STEMI and atrial fibrillation. Increased inflammatory cytokines  caused by COVID-19 and a history of cardiovascular disease may play a crucial role in cardiac injury. The patient did not undergo reperfusion therapy, considering the late arrival to the hospital, and was managed with anticoagulant therapy. The patient responded well to therapy. After 15 days of treatment in an isolation room and two weeks in a non-isolation room, the patient exhibited clinical improvement and could be treated as an outpatient case.  Patients with preexisting cardiovascular conditions are more likely to contract COVID-19, which significantly impacts the disease's course, treatment, and prognosis.


  1. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military medical research. 2020 Dec;7(1):1-23.
  2. Sugihantono A, Burhan E, Samuedro E, Aryati RW, Sitompul PA, Susilo A, et al. Pedoman pencegahan dan pengendalian coronavirus disease (Covid-19) revisi ke-5. Jakarta Selatan: Kementerian Kesehatan RI. 2020.
  3. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology. 2020 Jul 1;5(7):802-10.
  4. Yu CM, Wong RS, Wu EB, Kong SL, Wong J, Yip GW, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgraduate medical journal. 2006 Feb 1;82(964):140-4.
  5. Vlachakis PK, Tentolouris A, Kanakakis I. Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon. Journal of Thrombosis and Thrombolysis. 2020 Nov;50(4):809-13.
  6. Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, et al. COVID-19 and cardiac arrhythmias. Heart rhythm. 2020 Sep 1;17(9):1439-44.
  7. Gawałko M, Kapłon-Cieślicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. IJC Heart & Vasculature. 2020 Oct 1;30:100631.
  8. Rattanawong P, Shen W, El Masry H, Sorajja D, Srivathsan K, Valverde A, et al. Guidance on short‐term management of atrial fibrillation in coronavirus disease 2019. Journal of the American Heart Association. 2020 Jul 21;9(14):e017529.
  9. Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Progress in cardiovascular diseases. 2020 Sep 1;63(5):682-9.
  10. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. European heart journal. 2020 May 14.
  11. Rusu I, Turlacu M, Micheu MM. Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications. World Journal of Clinical Cases. 2022 Jan 1;10(3):762.
  12. Mandal P, Shah S, Chamlagain R, Rawal L, Gami R, Kartikey A, et al. Late onset ST-elevation myocardial infarction (STEMI) in patient with COVID-19: A case report from Nepal. Annals of Medicine and Surgery. 2022 Jun 1;78:103764.
  13. Hatab T, Moumneh MB, Akkawi AR, Ghazal M, Alam SE, Refaat MM. COVID-19: cardiovascular manifestations—a review of the cardiac effects. Journal of Geriatric Cardiology: JGC. 2022 Mar 3;19(3):245.
  14. Indonesia PD. Panduan Diagnosis dan Tatalaksana Penyakit Kardiovaskular pada Pandemi COVID-19. Guideline PERKI. 2020;1:1-02.
  15. Inciardi RM, Solomon SD, Ridker PM, Metra M. Coronavirus 2019 disease (COVID‐19), systemic inflammation, and cardiovascular disease. Journal of the American Heart Association. 2020 Aug 18;9(16):e017756.
  16. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. Basic to Translational Science. 2020 May 1;5(5):518-36.
  17. Alí A, Boutjdir M, Aromolaran AS. Cardiolipotoxicity, inflammation, and arrhythmias: role for interleukin-6 molecular mechanisms. Frontiers in Physiology. 2019 Jan 7;9:1866.
  18. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Modern Pathology. 2020 Jun;33(6):1007-14.
  19. Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19. Nature Reviews Immunology. 2022 May;22(5):270-2.
  20. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European journal of cardio-thoracic surgery. 2016 Nov 1;50(5).